Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadezhda Latysheva

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Journal of Internal Medicine|April 15, 2022
Plasma lipopolysaccharide-binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studiesSøren Beck Jensen, Nadezhda Latysheva, Kristian Hindberg, et al.
Journal of Thrombosis and Haemostasis : JTH|March 29, 2023
"A rapid, sensitive, and specific assay to measure tissue factor activity based on chromogenic determination of thrombin generation": replyBjarne Østerud, Nadezhda Latysheva, John-Bjarne Hansen, et al.
Thrombosis and Haemostasis|May 13, 2026
Revisiting Platelet-Associated Tissue Factor: Methodological Concerns in Flow Cytometry DetectionNadezhda Latysheva, Bjarne Østerud, John-Bjarne Hansen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2021
A rapid, sensitive, and specific assay to measure TF activity based on chromogenic determination of thrombin generationBjarne Østerud, Nadezhda Latysheva, Christian Schoergenhofer, et al.
Thrombosis Research|August 4, 2015
Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individualsIrina Starikova, Simin Jamaly, Antonio Sorrentino, et al.
Scientific Reports|November 23, 2018
Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using Nanoparticle Tracking AnalysisSimin Jamaly, Cathrine Ramberg, Randi Olsen, et al.
Research and Practice in Thrombosis and Haemostasis|January 3, 2022
Plasma procoagulant phospholipid clotting time and venous thromboembolism riskCathrine Ramberg, Line Wilsgård, Nadezhda Latysheva, et al.
Journal of Thrombosis and Haemostasis : JTH|January 9, 2022
Plasma levels of platelet-derived microvesicles are associated with risk of future venous thromboembolismOmri Snir, Line Wilsgård, Nadezhda Latysheva, et al.
Research and Practice in Thrombosis and Haemostasis|January 15, 2025
Effect of plasma levels of factor VIII according to procoagulant phospholipids on the risk of future venous thromboembolismMagnus S Edvardsen, Ellen-Sofie Hansen, Thor Ueland, et al.
Thrombosis Research|July 18, 2018
Associations between complement pathways activity, mannose-binding lectin, and odds of unprovoked venous thromboembolismIna Isabella Høiland, Robin Amanda Liang, Kristian Hindberg, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Journal of Internal Medicine|April 15, 2022
Plasma lipopolysaccharide-binding protein is a biomarker for future venous thromboembolism: Results from discovery and validation studiesSøren Beck Jensen, Nadezhda Latysheva, Kristian Hindberg, et al.
Journal of Thrombosis and Haemostasis : JTH|March 29, 2023
"A rapid, sensitive, and specific assay to measure tissue factor activity based on chromogenic determination of thrombin generation": replyBjarne Østerud, Nadezhda Latysheva, John-Bjarne Hansen, et al.
Thrombosis and Haemostasis|May 13, 2026
Revisiting Platelet-Associated Tissue Factor: Methodological Concerns in Flow Cytometry DetectionNadezhda Latysheva, Bjarne Østerud, John-Bjarne Hansen, et al.
Journal of Thrombosis and Haemostasis : JTH|November 25, 2021
A rapid, sensitive, and specific assay to measure TF activity based on chromogenic determination of thrombin generationBjarne Østerud, Nadezhda Latysheva, Christian Schoergenhofer, et al.
Thrombosis Research|August 4, 2015
Differential expression of plasma miRNAs in patients with unprovoked venous thromboembolism and healthy control individualsIrina Starikova, Simin Jamaly, Antonio Sorrentino, et al.
Scientific Reports|November 23, 2018
Impact of preanalytical conditions on plasma concentration and size distribution of extracellular vesicles using Nanoparticle Tracking AnalysisSimin Jamaly, Cathrine Ramberg, Randi Olsen, et al.
Research and Practice in Thrombosis and Haemostasis|January 3, 2022
Plasma procoagulant phospholipid clotting time and venous thromboembolism riskCathrine Ramberg, Line Wilsgård, Nadezhda Latysheva, et al.
Journal of Thrombosis and Haemostasis : JTH|January 9, 2022
Plasma levels of platelet-derived microvesicles are associated with risk of future venous thromboembolismOmri Snir, Line Wilsgård, Nadezhda Latysheva, et al.
Research and Practice in Thrombosis and Haemostasis|January 15, 2025
Effect of plasma levels of factor VIII according to procoagulant phospholipids on the risk of future venous thromboembolismMagnus S Edvardsen, Ellen-Sofie Hansen, Thor Ueland, et al.
Thrombosis Research|July 18, 2018
Associations between complement pathways activity, mannose-binding lectin, and odds of unprovoked venous thromboembolismIna Isabella Høiland, Robin Amanda Liang, Kristian Hindberg, et al.
Pageof 2